Engetix and Takeda announce expanded collaboration for anti-fibrotic therapies
Engitix and Takeda will extend existing agreement to collaborate extensively in the development of therapeutics in IBD
Read More
Tag: Anti-fibrotic
- Arvinas reports strong phase 1 results for ARV-102 in Parkinson’s disease
- Alzecure shares new preclinical data on NeuroRestore ACD856 at AD/PD conference
- Samsung Bioepis signs partnership with Sandoz for next‑generation biosimilars
- Atrogi begins dosing first subjects in human trial of ATR-258
- R1 Therapeutics launches with $77.5m to advance hyperphosphatemia treatment
